Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Steroid receptor coactivators 1 and 2 mediate fetal-to-maternal signaling that initiates parturition
Lu Gao, … , Bert W. O’Malley, Carole R. Mendelson
Lu Gao, … , Bert W. O’Malley, Carole R. Mendelson
Published June 22, 2015
Citation Information: J Clin Invest. 2015;125(7):2808-2824. https://doi.org/10.1172/JCI78544.
View: Text | PDF
Research Article Reproductive biology

Steroid receptor coactivators 1 and 2 mediate fetal-to-maternal signaling that initiates parturition

  • Text
  • PDF
Abstract

The precise mechanisms that lead to parturition are incompletely defined. Surfactant protein-A (SP-A), which is secreted by fetal lungs into amniotic fluid (AF) near term, likely provides a signal for parturition; however, SP-A–deficient mice have only a relatively modest delay (~12 hours) in parturition, suggesting additional factors. Here, we evaluated the contribution of steroid receptor coactivators 1 and 2 (SRC-1 and SRC-2), which upregulate SP-A transcription, to the parturition process. As mice lacking both SRC-1 and SRC-2 die at birth due to respiratory distress, we crossed double-heterozygous males and females. Parturition was severely delayed (~38 hours) in heterozygous dams harboring SRC-1/-2–deficient embryos. These mothers exhibited decreased myometrial NF-κB activation, PGF2α, and expression of contraction-associated genes; impaired luteolysis; and elevated circulating progesterone. These manifestations also occurred in WT females bearing SRC-1/-2 double-deficient embryos, indicating that a fetal-specific defect delayed labor. SP-A, as well as the enzyme lysophosphatidylcholine acyltransferase-1 (LPCAT1), required for synthesis of surfactant dipalmitoylphosphatidylcholine, and the proinflammatory glycerophospholipid platelet-activating factor (PAF) were markedly reduced in SRC-1/-2–deficient fetal lungs near term. Injection of PAF or SP-A into AF at 17.5 days post coitum enhanced uterine NF-κB activation and contractile gene expression, promoted luteolysis, and rescued delayed parturition in SRC-1/-2–deficient embryo-bearing dams. These findings reveal that fetal lungs produce signals to initiate labor when mature and that SRC-1/-2–dependent production of SP-A and PAF is crucial for this process.

Authors

Lu Gao, Elizabeth H. Rabbitt, Jennifer C. Condon, Nora E. Renthal, John M. Johnston, Matthew A. Mitsche, Pierre Chambon, Jianming Xu, Bert W. O’Malley, Carole R. Mendelson

×

Figure 4

LPCAT1 expression and PAF synthesis and secretion are reduced in lungs of SRC-1/-2 double-deficient fetuses.

Options: View larger image (or click on image) Download as PowerPoint
LPCAT1 expression and PAF synthesis and secretion are reduced in lungs o...
(A) Lpcat1 mRNA in lungs of WT and SRC-1/-2 dhet (dhet) fetuses from 15.5 dpc to term (n = 5 mice per time point). (B) Representative immunoblot of LPCAT1 protein in lungs of WT or SRC-1/-2 dhet fetuses from 15.5 dpc to term (n = 2–3 per time point). (C) Lpcat1 mRNA in lungs of 18.5 dpc WT (n = 3), dhet (n = 14), dKO (n = 3), KO/het (n = 6), het/KO (n = 6), KO/WT (n = 3), het/WT (n = 13), and WT/het (n = 4) fetuses. (D) LPCAT1 protein in fetal lungs at 18.5 dpc. Representative immunoblot according to genotype, and densitometric scans of immunoblots of LPCAT1 normalized to β-actin for WT (n = 7), dhet (n = 8), KO/het (n = 8), and dKO (n = 4) fetuses are shown. (E) PAF in WT fetal lungs at 15.5 (n = 3), 16.5 (n = 3), 17.5 (n = 7), 18.5 (n = 5), and 19.5 (n = 3) dpc. (F) PAF in AF surrounding WT fetuses at 15.5 (n = 3), 16.5 (n = 3), 17.5 (n = 7), 18.5 (n = 6), and 19.5 (n = 4) dpc. (G) PAF in 18.5 dpc fetal lungs of WT (n = 5), SRC-1 KO (n = 4), SRC-2 KO (n = 3), dhet (n = 7), and dKO (n = 6). (H) PAF in AF surrounding 18.5 dpc WT (n = 6), SRC-1 KO (n = 4), SRC-2 KO (n = 4), dhet (n = 6), and dKO (n = 5) fetuses. (F and H) In the box-and-whisker plots, horizontal bars indicate the medians, boxes indicate 25th to 75th percentiles, and whiskers indicate 10th and 90th percentiles. Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001; #P < 0.05, ##P < 0.01 compared with WT at same dpc (ANOVA).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts